Induction FOLFOX With or Without Aflibercept Followed by Chemoradiation in High Risk Locally Advanced Rectal Cancer

NCT02340949 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer

Interventions

DRUG: Aflibercept
DRUG: 5-Fluoruracil
DRUG: Oxaliplatin
DRUG: Leucovorin

Sponsor

Grupo Espanol Multidisciplinario del Cancer Digestivo

Collaborators

[object Object]